Daily
Newsletter
1.
Lupin
received a final USFDA approval for Tetrabenazine Tablets, 12.5 and 25 mg. This
is a generic version of Valeant Pharma’s Xenazine tablet 12.5 mg and 25 mg.
2.
Axis Bank
commenced succession process for a new chief executive officer and managing
director and appoints Egon Zehnder to succession conduct process.
3.
Adani
Enterprises along with Prakash Asphaltings and Toll Highways (India) have
incorporated a joint venture company Bilaspur Pathrapali Road Private Limited in
the ratio of 74:26.
4.
Reliance
says it is not aware of any further investigation undertaken by the I-T
department regarding the Rs6,500cr foreign direct investment by Biometrix in
the company’s group entities.
5.
DLF has
sought to allay concerns about slow pace of monetization of land assets.
6.
NMDC cuts
prices of lump ore and fines by Rs100 each to Rs2,900 per tonne and Rs2,560 per
tonne with effect from April 18.
7.
Bharti
Airtel shares gains on the back of positive news flow that company announces
30GB free data for users upgrading to 4G.
Missed call
@8817002233,WHATSAPP NO. 8602780449
Mail Us =
starindiamarket@gmail.com
No comments:
Post a Comment